Paper19633031
Keishibukuryogan reduces renal injury in the early stage of renal failure in the remnant kidney model.
Nakagawa T and 8 others. Evid Based Complement Alternat Med, 2011. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Keishibukuryogan reduces renal injury in the early stage of renal failure in the remnant kidney model. Papers, record 19633031. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19633031
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Keishibukuryogan reduces renal injury in the early stage of renal failure in the remnant kidney model.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9437375 | Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry? | Arch Intern Med | 1998 | https://conductscience.org/library/papers/9437375 | PubMed |
| 2 | 8158904 | Macrophages in renal injury. | Kidney Int Suppl | 1994 | https://conductscience.org/library/papers/8158904 | PubMed |
| 3 | 15905195 | Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats. | Nephrol Dial Transplant | 2005 | https://conductscience.org/library/papers/15905195 | PubMed |
| 4 | 940276 | Pathogenesis of the glomerulopathy associated with renal infarction in rats. | Kidney Int | 1976 | https://conductscience.org/library/papers/940276 | PubMed |
| 5 | 4173786 | Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. | Lancet | 1968 | https://conductscience.org/library/papers/4173786 | PubMed |
| 6 | 11012882 | Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II. | Kidney Int | 2000 | https://conductscience.org/library/papers/11012882 | PubMed |
| 7 | 3345677 | Natural course of the development of histological lesions after 5/6 nephrectomy. | Contrib Nephrol | 1988 | https://conductscience.org/library/papers/3345677 | PubMed |
| 8 | 1313122 | Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. | Kidney Int | 1992 | https://conductscience.org/library/papers/1313122 | PubMed |
| 9 | 9140991 | Pathogenesis of diabetic nephropathy: a radical approach. | Nephrol Dial Transplant | 1997 | https://conductscience.org/library/papers/9140991 | PubMed |
| 10 | 15070171 | Effects of Keishi-bukuryo-gan on vascular function and hemorheological factors in spontaneously diabetic (WBN/kob) rats. | Phytomedicine | 2004 | https://conductscience.org/library/papers/15070171 | PubMed |
| 11 | 9407465 | Macrophage and myofibroblast proliferation in remnant kidney: role of angiotensin II. | Kidney Int Suppl | 1997 | https://conductscience.org/library/papers/9407465 | PubMed |
| 12 | 8178943 | Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin). | Am J Pathol | 1994 | https://conductscience.org/library/papers/8178943 | PubMed |
| 13 | 8007597 | Macrophages in acute glomerular inflammation. | Kidney Int | 1994 | https://conductscience.org/library/papers/8007597 | PubMed |
| 14 | 9294829 | Osteopontin in chronic puromycin aminonucleoside nephrosis. | J Am Soc Nephrol | 1997 | https://conductscience.org/library/papers/9294829 | PubMed |
| 15 | 9075120 | Focal glomerulosclerosis in the remnant kidney model--an inflammatory disease mediated by cytokines. | Nephrol Dial Transplant | 1997 | https://conductscience.org/library/papers/9075120 | PubMed |
| 16 | 17123761 | Protective effects of keishibukuryogan on the kidney of spontaneously diabetic WBN/Kob rats. | J Ethnopharmacol | 2007 | https://conductscience.org/library/papers/17123761 | PubMed |
| 17 | 9530275 | Differential effects of ACE and AT1 receptor inhibition on chemoattractant and adhesion molecule synthesis. | Am J Physiol | 1998 | https://conductscience.org/library/papers/9530275 | PubMed |
| 18 | 16109081 | Role of impaired peritubular capillary and hypoxia in progressive interstitial fibrosis after 56 subtotal nephrectomy of rats. | Nephrology (Carlton) | 2005 | https://conductscience.org/library/papers/16109081 | PubMed |
| 19 | 8004960 | Transforming growth factor-beta and extracellular matrix deposition in the kidney. | Contrib Nephrol | 1994 | https://conductscience.org/library/papers/8004960 | PubMed |
| 20 | 7643523 | Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. | Kidney Int | 1995 | https://conductscience.org/library/papers/7643523 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37680217 | Efficacy of keishibukuryogan for hot flashes in prostate cancer patients receiving androgen deprivation therapy: a sub-analysis focusing on hormonal and cytokine levels. | Transl Androl Urol | 2023 | https://conductscience.org/library/papers/37680217 | PubMed |
| 35529925 | The Multiple Pharmacologic Functions and Mechanisms of Action of Guizhi Fuling Formulation. | Evid Based Complement Alternat Med | 2022 | https://conductscience.org/library/papers/35529925 | PubMed |
| 35004802 | A Review on the Mechanism and Application of Keishibukuryogan. | Front Nutr | 2021 | https://conductscience.org/library/papers/35004802 | PubMed |
| 30741979 | Phosphate binding by sucroferric oxyhydroxide ameliorates renal injury in the remnant kidney model. | Sci Rep | 2019 | https://conductscience.org/library/papers/30741979 | PubMed |
| 30235697 | Traditional Chinese medicine decreases the obstructive uropathy risk in uterovaginal prolapse: A nationwide population-based study. | Medicine (Baltimore) | 2018 | https://conductscience.org/library/papers/30235697 | PubMed |
| 24864155 | Protective Effects of Bu-Shen-Huo-Xue Formula against 5/6 Nephrectomy-Induced Chronic Renal Failure in Rats. | Evid Based Complement Alternat Med | 2014 | https://conductscience.org/library/papers/24864155 | PubMed |
| 20177750 | Study of blood porphyrin spectral profile for diagnosis of chronic renal failure. | J Fluoresc | 2010 | https://conductscience.org/library/papers/20177750 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| REN | 5972 | PubTator's text mining | https://conductscience.org/library/genes/5972 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19633031
GET https://conductscience.org/api/papers/v1/19633031/references?page=2